Characteristics | No of patients (%) |
---|---|
All patients | 401 (100) |
Age | |
Median (range) | 58 (29–91) |
< 50 years | 80 (20) |
≥ 50 years | 321 (80) |
Mode of detection | |
Screening detected | 167 (42) |
Clinical signs | 232 (58) |
Unknown | 2 |
Tumor size | |
≤ 20mm | 263 (66) |
> 20mm | 136 (34) |
Unknown | 2 |
Node status | |
N0 | 233 (60) |
N+ | 157 (40) |
Unknown | 11 |
NHG | |
1 | 77 (20) |
2 | 221 (56) |
3 | 94 (24) |
Unknown | 9 |
ER status | |
Positive | 312 (80) |
Negative | 77 (20) |
Unknown | 12 |
PR status | |
Positive | 242 (62) |
Negative | 147 (38) |
Unknown | 12 |
Surgery breast | |
Mastectomy | 157 (39) |
Breast concerving surgery | 243 (61) |
Unknown | 1 |
Surgery axilla | |
Axillary dissection | 247 (63) |
Sentinel node biopsy | 142 (37) |
No Surgery (incl in clinical trial) | 12 |
Adjuvant treatment No adjuvant treatment | 137 (34) |
Only Chemotherapy | 65 (16) |
Only Endocrine therapy | 197 (49) |
Missing | 2 |
Radiotherapy | |
Breast | 198 (49) |
Locoregional lymph nodes | 35 (9) |
Breast + locoregional | 39 (10) |